Clinical Trial Update: Recurrent Campylobacter Bacteraemia in Immunocompromised Patients

View source ↗

Summary

Clinical trial update showing a study on recurrent Campylobacter bacteremia in immunocompromised patients is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Campylobacteriosis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Campylobacter Infections | Status: NOT_YET_RECRUITING